These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 2465099

  • 1. Relation of baseline characteristics to suppression of ventricular arrhythmias during placebo and active antiarrhythmic therapy in patients after myocardial infarction.
    Anderson JL, Hallstrom AP, Griffith LS, Ledingham RB, Reiffel JA, Yusuf S, Barker AH, Fowles RE, Young JB.
    Circulation; 1989 Mar; 79(3):610-9. PubMed ID: 2465099
    [Abstract] [Full Text] [Related]

  • 2. Recruitment and baseline description of patients in the Cardiac Arrhythmia Pilot Study. The Cardiac Arrhythmia Pilot Study (CAPS) investigators.
    Am J Cardiol; 1988 Apr 01; 61(10):704-13. PubMed ID: 2451414
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Predicting mortality after myocardial infarction from the response of RR variability to antiarrhythmic drug therapy.
    Bigger JT, Rolnitzky LM, Steinman RC, Fleiss JL.
    J Am Coll Cardiol; 1994 Mar 01; 23(3):733-40. PubMed ID: 7509355
    [Abstract] [Full Text] [Related]

  • 5. Interaction of baseline characteristics with the hazard of encainide, flecainide, and moricizine therapy in patients with myocardial infarction. A possible explanation for increased mortality in the Cardiac Arrhythmia Suppression Trial (CAST).
    Anderson JL, Platia EV, Hallstrom A, Henthorn RW, Buckingham TA, Carlson MD, Carson PE.
    Circulation; 1994 Dec 01; 90(6):2843-52. PubMed ID: 7994829
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Implications of the Cardiac Arrhythmia Suppression Trial for antiarrhythmic drug treatment.
    Bigger JT.
    Am J Cardiol; 1990 Feb 20; 65(8):3D-10D; discussion 68D-71D. PubMed ID: 2106253
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of ventricular arrhythmias after CAST.
    Tonkin AM.
    Med J Aust; 1992 Apr 06; 156(7):488-92. PubMed ID: 1372950
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. CAST and beyond. Implications of the Cardiac Arrhythmia Suppression Trial. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.
    Akhtar M, Breithardt G, Camm AJ, Coumel P, Janse MJ, Lazzara R, Myerburg RJ, Schwartz PJ, Waldo AL, Wellens HJ.
    Circulation; 1990 Mar 06; 81(3):1123-7. PubMed ID: 1689621
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Biobehavioral factors in Cardiac Arrhythmia Pilot Study (CAPS). Review and examination.
    Sloan RP, Bigger JT.
    Circulation; 1991 Apr 06; 83(4 Suppl):II52-7. PubMed ID: 1706967
    [Abstract] [Full Text] [Related]

  • 20. The Cardiac Arrhythmia Suppression Trial: Implications for nursing practice.
    Kellen JC, Ettinger A, Todd L, Brezsnyak ML, Campion J, McBride R, Thomas S, Corum J, Schron E.
    Am J Crit Care; 1996 Jan 06; 5(1):19-25. PubMed ID: 8680488
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.